Inborn oxidative phosphorylation defect as risk factor for propofol infusion syndrome

Propofol is an anesthetic agent widely used for induction and maintenance of anesthesia, and sedation in children. Although generally considered as reliable and safe, administration of propofol can occasionally induce a potentially fatal complication known as propofol infusion syndrome (PRIS). Mitoc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Vanlander, Arnaud Vincent (VerfasserIn) , Okun, Jürgen G. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 19 January 2012
In: Acta anaesthesiologica Scandinavica
Year: 2012, Jahrgang: 56, Heft: 4, Pages: 520-525
ISSN:1399-6576
DOI:10.1111/j.1399-6576.2011.02628.x
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1111/j.1399-6576.2011.02628.x
Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1399-6576.2011.02628.x
Volltext
Verfasserangaben:A.V. Vanlander, P.G. Jorens, J. Smet, B. De Paepe, W. Verbrugghe, G.G. Van Den Eynden, F. Meire, P. Pauwels, N. Van Der Aa, S. Seneca, W. Lissens, J.G. Okun and R. Van Coster

MARC

LEADER 00000caa a2200000 c 4500
001 1582148538
003 DE-627
005 20220815034735.0
007 cr uuu---uuuuu
008 181022s2012 xx |||||o 00| ||eng c
024 7 |a 10.1111/j.1399-6576.2011.02628.x  |2 doi 
035 |a (DE-627)1582148538 
035 |a (DE-576)512148538 
035 |a (DE-599)BSZ512148538 
035 |a (OCoLC)1341020397 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Vanlander, Arnaud Vincent  |e VerfasserIn  |0 (DE-588)1136588043  |0 (DE-627)893146927  |0 (DE-576)490666469  |4 aut 
245 1 0 |a Inborn oxidative phosphorylation defect as risk factor for propofol infusion syndrome  |c A.V. Vanlander, P.G. Jorens, J. Smet, B. De Paepe, W. Verbrugghe, G.G. Van Den Eynden, F. Meire, P. Pauwels, N. Van Der Aa, S. Seneca, W. Lissens, J.G. Okun and R. Van Coster 
264 1 |c 19 January 2012 
300 |b Illustrationen 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 22.10.2018 
520 |a Propofol is an anesthetic agent widely used for induction and maintenance of anesthesia, and sedation in children. Although generally considered as reliable and safe, administration of propofol can occasionally induce a potentially fatal complication known as propofol infusion syndrome (PRIS). Mitochondrial dysfunction has been implicated in the pathogenesis of PRIS. We report on an adult patient with Leber hereditary optic neuropathy (LHON) who developed PRIS. He was a carrier of the m.3460G>A mutation, one of the major three pathogenic point mutations associated with LHON. The propositus was blind and underwent propofol sedation after severe head injury. Five days after start of propofol infusion, the patient died. The activity of complex I of the oxidative phosphorylation (OXPHOS) system was severely deficient in skeletal muscle. Our observation indicates that fulminate PRIS can occur in an adult patient with an inborn OXPHOS defect and corroborates the hypothesis that PRIS is caused by inhibition of the OXPHOS system. 
700 1 |a Okun, Jürgen G.  |d 1968-  |e VerfasserIn  |0 (DE-588)121578232  |0 (DE-627)705551415  |0 (DE-576)292781296  |4 aut 
773 0 8 |i Enthalten in  |t Acta anaesthesiologica Scandinavica  |d Oxford [u.a.] : Wiley-Blackwell, 1957  |g 56(2012), 4, Seite 520-525  |h Online-Ressource  |w (DE-627)320435709  |w (DE-600)2004319-3  |w (DE-576)09114261X  |x 1399-6576  |7 nnas  |a Inborn oxidative phosphorylation defect as risk factor for propofol infusion syndrome 
773 1 8 |g volume:56  |g year:2012  |g number:4  |g pages:520-525  |g extent:6  |a Inborn oxidative phosphorylation defect as risk factor for propofol infusion syndrome 
856 4 0 |u http://dx.doi.org/10.1111/j.1399-6576.2011.02628.x  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1399-6576.2011.02628.x  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20181022 
993 |a Article 
994 |a 2012 
998 |g 121578232  |a Okun, Jürgen G.  |m 121578232:Okun, Jürgen G.  |d 910000  |d 910500  |e 910000PO121578232  |e 910500PO121578232  |k 0/910000/  |k 1/910000/910500/  |p 12 
999 |a KXP-PPN1582148538  |e 3029355136 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedKey":"2012","dateIssuedDisp":"19 January 2012"}],"title":[{"title":"Inborn oxidative phosphorylation defect as risk factor for propofol infusion syndrome","title_sort":"Inborn oxidative phosphorylation defect as risk factor for propofol infusion syndrome"}],"person":[{"family":"Vanlander","role":"aut","display":"Vanlander, Arnaud Vincent","given":"Arnaud Vincent"},{"role":"aut","display":"Okun, Jürgen G.","family":"Okun","given":"Jürgen G."}],"language":["eng"],"physDesc":[{"extent":"6 S.","noteIll":"Illustrationen"}],"recId":"1582148538","id":{"doi":["10.1111/j.1399-6576.2011.02628.x"],"eki":["1582148538"]},"name":{"displayForm":["A.V. Vanlander, P.G. Jorens, J. Smet, B. De Paepe, W. Verbrugghe, G.G. Van Den Eynden, F. Meire, P. Pauwels, N. Van Der Aa, S. Seneca, W. Lissens, J.G. Okun and R. Van Coster"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 22.10.2018"],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"part":{"year":"2012","extent":"6","text":"56(2012), 4, Seite 520-525","volume":"56","pages":"520-525","issue":"4"},"language":["eng"],"disp":"Inborn oxidative phosphorylation defect as risk factor for propofol infusion syndromeActa anaesthesiologica Scandinavica","recId":"320435709","id":{"doi":["10.1111/(ISSN)1399-6576"],"eki":["320435709"],"zdb":["2004319-3"],"issn":["1399-6576"]},"origin":[{"dateIssuedKey":"1957","publisher":"Wiley-Blackwell ; Munksgaard ; Blackwell Munksgaard ; Blackwell","publisherPlace":"Oxford [u.a.] ; Copenhagen ; Oxford ; Oxford [u.a.]","dateIssuedDisp":"1957-"}],"pubHistory":["1.1957 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"title_sort":"Acta anaesthesiologica Scandinavica","title":"Acta anaesthesiologica Scandinavica"}],"note":["Einzelne Bände auch als Supplement bezeichnet","Gesehen am 09.02.09"]}]} 
SRT |a VANLANDERAINBORNOXID1920